ArticleOncotarget2017

Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer.

Yuanyuan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.